Ar a 6 _ i o Dr.U.Noack-Laboratorium fr Angewandte Biologie 1-Decanol, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro- Respiration Inhibition Test with Activated Sludge acc. to OECD Guideline No. 209 for Testing of Chemicals adopted April 4, 1984 Sponsor Telomer Research Project A sahi Glass Atofina Clariant Daikin Industries Ltd Dupont Author Martina Noack Test Facility Dr .U .N o ack-Laborato rium FR ANGEWANDTE BIOLOGIE Kthe-Paulus-Str. 1 D -31157 Sarstedt Laboratory Project ID Project-No. 020109CK Study-No.
refid# vVZZ9j8ZX3GOE1ZXJr7EJ26yE30 pages
74*UA6_ I3/ 1V # &J 4-f/ March 21,2003 1301 K STREET.
refid# bByE1zYV1ZJnRpmq2g3qBBRQo25 pages
February 7, 2003 DRAFT Study Plan: Impurity Analysis of Products R A -- / *2- 7 & Telomer Research Program The following is a proposed study plan for the analysis of PFOA in 11 different telomer-based products (see below).
refid# kDjnZwxzD644JaYOa9XBZ9rRJ2 pages
AR226-1399 \ \ T.
refid# g2vvON580QYaLrJ1yYk6OZZOJ7 pages
AR226-1418 OPPT-2003-0012: Perfluorooctanoic Acid (PFOA), Fluorinated Telomers; Request for Comment; Solicitation of Interested Parties fo r Enforceable Consent Agreement Development; and Notice of Public Meeting OPPT Docket in which EPA is identifying potential human health concerns about PFOA, requesting comments and additional information, and soliciting interested parties to participate in negotiations on enforceable consent agreements to produce additional data.
refid# OznY4QR4q0z4wX5enOBrNZXaj1 page
Z-45 RCV 12 TB mm t u Aiui*t c a w E .
refid# gQ2Jaz6gLbaMwRno9pvK4KGa3 pages
April 22, 2003 Christine !
refid# 2NzaG8b9BkKORmao6ZzeX81Qg2 pages
O A UCl h l / 7A* D A IK IN A M E R IC A , IMG.
refid# LD173onjjVbEJLa9KrZv2bkQ2 pages
3M FLUOROCHEMICAL SUBMISSIONS February, 2002 - May 11, 2004 TOXICOLOGY, EPIDEMIOLOGY AND MEDICAL SURVEILLANCE Click on Study Title to View Report Multiple Chemicals PAGE 1, 2, 3 Human Sera/Medical Surveillance/Epidemiology 1.
refid# Qg7gk1kobjxvk0Lwz3LZOLwOE3 pages
Available online at www.sciencedirect.com SCIE NC E DIRECT Regulatory Toxicology and Pharmacology 39 (2004) 363-380 Regulatory Toxicology and Pharmacology www.elsevier.com/locate/yrtph Characterization of risk for general population exposure to perfluorooctanoate John L.
refid# reRvjmydRk9QzRyjjErdXDKmV18 pages
Bladder Cancer in Perfluorooctanesulfonyl Fluoride Manufacturing Workers Final Report Bruce H.
refid# LpQG98g6rEO4QKdwVyMdpwjq529 pages
/}(Utf-0563 FINAL REPORT PROTOCOL 418-008 COMBINED ORAL (GAVAGE) FERTILITY, DEVELOPMENTAL AND PERINATAL/POSTNATAL REPRODUCTION TOXICITY STUDY OF PFOS IN RATS SPONSOR'S STUDY NUMBER: 6295.9 FINAL REPORT DATE: 10 JUNE 1999 00133 PROTOCOL 418-008 COMBINED ORAL (GAVAGE) FERTILITY, DEVELOPMENTAL AND PERINATAL/POSTNATAL REPRODUCTION TOXICITY STUDY OF PFOS IN RATS SPONSOR'S STUDY NUMBER: 6295.9 TABLE OF CONTENTS SUBJECT 1.
refid# mrL6eXd48XZ6oDLoqmpm2KdB645 pages
3M Chemicals 3M Center St.
refid# a1GXNxw7QGdnx2KqxZGQjxgja2 pages
AZ S.6 -. 0&& ppi Mac 2MSEP-6 Png; 5 ?
refid# RJG5zMK8JmZ11Gn867b140Ybn11 pages
SCUpeanctiPtvieaerdlroirssafMtita.deGiiddnMieicMogeovlediCadiScinhcitniunirnaudiaridgCddeoieolVlLsetLaaravoovnoraoro P.za I.
refid# da196pkRnRBLQDzvprExjgrq08 pages